Oxyresveratrol

CAS No. 29700-22-9

Oxyresveratrol( trans-Oxyresveratrol )

Catalog No. M18383 CAS No. 29700-22-9

Oxyresveratro is useful to trauma models, as toxicity to glia could be beneficial by inhibiting reactive gliosis.

Oxyresveratro is useful to trauma models, as toxicity to glia could be beneficial by inhibiting reactive gliosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 27 In Stock
100MG 41 In Stock
500MG 138 In Stock
1G 221 In Stock

Biological Information

  • Product Name
    Oxyresveratrol
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxyresveratro is useful to trauma models, as toxicity to glia could be beneficial by inhibiting reactive gliosis.
  • Description
    Oxyresveratro can inhibit tyrosinase activity. Oxyresveratro is useful to trauma models, as toxicity to glia could be beneficial by inhibiting reactive gliosis. Oxyresveratrol has antioxidant activity, can reduce neuronal oxidative damage and protect hepatocytes against oxidative stress and mitochondrial dysfunction, which may be associated with activation of Nrf2.
  • In Vitro
    Cultures of the murine microglial cell line N9 and primary mixed glial cultures were used to test the drug effects of NO production upon expression of the inducible isoform of nitric oxide synthase (iNOS). Oxyresveratrol considerably diminished NO (nitrite) levels (IC50 of 45.31 μM) in murine microglial cells. Oxyresveratrol can inhibit DOPA oxidase activity, cyclooxygenase, and rat liver mitochondrial ATPase activity. Oxyresveratrol exhibits 63.3% inhibition at 100 μM and an IC50 value of 52.7 μM on the murine tyrosinase activity. Oxyresveratrol exhibits a dose-dependent inhibitory effect on L-tyrosine oxidation by the murine tyrosinase but does not inhibit the promoter activity of the enzyme gene. Oxyresveratrol exhibits significant inhibitory effects at 10 μM and higher concentrations on murine tyrosinase activity.
  • In Vivo
    Oxyresveratrol (2-30 mg/kg; intraperitoneal injection; twice) treatment reduces the brain infarct volume in MCAO rats. Oxyresveratrol treatment diminishes cytochrome c release and decreased caspase-3 activation, and reduces the number of apoptotic nuclei in ischemic brain in MCAO rats. Animal Model:Adult male Wistar rats (300-350 g) with middle cerebral artery occlusion (MCAO)Dosage:2 mg/kg, 10 mg/kg, 20 mg/kg and 30 mg/kg Administration:Intraperitoneal injection; twice (at the time of occlusion and at the time of reperfusion)Result:Reduced the brain infarct volume in MCAO rats.
  • Synonyms
    trans-Oxyresveratrol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Tyrosinase
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    29700-22-9
  • Formula Weight
    244.24
  • Molecular Formula
    C14H12O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 34 mg/mL; 139.21 mM
  • SMILES
    C1=CC(=C(C=C1O)O)C=CC2=CC(=CC(=C2)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products